The ANKZF1 Knockout HeLa Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal population of HeLa cells with targeted disruption of the ANKZF1 gene. This loss-of-function model enables the study of ANKZF1-dependent processes in a human epithelial context. The knockout is achieved through CRISPR/Cas9-mediated gene disruption, resulting in a heterogeneous cell pool ideal for investigating ANKZF1 function without clonal artifacts.
HeLa cells, derived from an HPV18-positive cervical adenocarcinoma, are a widely used epithelial model in cancer biology and mitochondrial research. Their robust growth and well-characterized signaling networks make them suitable for interrogating mitochondrial RNA processing and ribosome-associated quality control pathways. The HPV18 oncoproteins perturb host cell homeostasis, providing a relevant background for studying stress-induced mitochondrial and proteostatic responses.
ANKZF1 encodes an endonuclease that associates with the 60S ribosomal subunit and mitochondria, where it cleaves pre-tRNA CCA tails and poly(A) tails of mRNAs. It functions downstream of the unfolded protein response and mitochondrial retrograde signaling, and upstream of mitochondrial tRNA maturation, mitochondrial protein synthesis, and 60S ribosome recycling. ANKZF1 physically interacts with PNPT1 and the VCP/p97 complex, and cooperates with LTN1 and NEMF within the ribosome-associated quality control (RQC) machinery. Through these interactions, ANKZF1 maintains mitochondrial RNA integrity and clears stalled translation complexes, thereby preserving proteostasis under metabolic stress.
In the HeLa context, ANKZF1 knockout compromises mitochondrial RNA processing and RQC, sensitizing cells to mitochondrial stressors. This polyclonal knockout population allows researchers to monitor heterogeneous cellular outcomes, simulating physiological variability. The HPV18-positive background may additionally influence mitochondrial-nuclear crosstalk, offering insights into how oncogenic transformation alters mitochondrial quality control. Consequently, this model is valuable for dissecting the interplay between mitochondrial dysfunction and cancer cell survival.
Applications include western blotting and immunofluorescence to verify ANKZF1 loss and assess mitochondrial morphology, RT-qPCR and RNA-seq to profile mitochondrial tRNA maturation, and ribosome profiling to examine RQC efficiency. Researchers can employ co-immunoprecipitation to map ANKZF1 interactors, tRNA cleavage assays to measure endonuclease activity, and high-resolution respirometry to evaluate mitochondrial function. Cell viability assays under mitochondrial stress further elucidate protective roles. For additional information and technical support, please contact Ascent Research.
